Full Text View
Tabular View
No Study Results Posted
Related Studies
Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN
This study has been completed.
Study NCT00301613   Information provided by Nanjing University School of Medicine

First Received on March 10, 2006.   Last Updated on May 25, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Henoch-Schoenlein Purpura
Nephritis
Additional conditions recognized in this trial
Purpura
Purpura, Schoenlein-Henoch
More general conditions related to this trial
Blood Coagulation Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhage
Hemorrhagic Disorders
Hemostatic Disorders
Hypersensitivity
Immune Complex Diseases
Immune System Diseases
Kidney Diseases
Pathologic Processes
Signs and Symptoms
Skin Manifestations
Urologic Diseases
Vascular Diseases
Vasculitis
Interventions listed in this trial
Mycophenolate mofetil
Additional drug interventions recognized in this trial
Mycophenolic Acid
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Nanjing University School of Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services